Direct and indirect lactate oxidation in trained and untrained men.
Chi-An W Emhoff, Laurent A Messonnier, Michael A Horning...
https://pubmed.ncbi.nlm.nih.gov/23788576Actively Recruiting
Led by Ricardo Mora · Updated on 2026-02-23
24
Participants Needed
1
Research Sites
34 weeks
Total Duration
R
Ricardo Mora
Lead Sponsor
U
University of Castilla-La Mancha
Collaborating Sponsor
Researchers are investigating whether higher blood lactate levels in people with metabolic syndrome contribute to their reduced fat breakdown and glucose tolerance. The study compares metabolically healthy individuals to those with metabolic syndrome, focusing on how elevated lactate affects carbohydrate and fat metabolism at rest, during exercise, and after an oral glucose load. This research uses advanced metabolic assessments to better understand lactate's role beyond being a simple by-product. The study involves two groups: metabolically healthy participants who receive either an intravenous sodium lactate infusion to raise blood lactate to levels seen in metabolic syndrome or a saline infusion as a control, and metabolic syndrome participants who receive only the saline infusion. Each trial includes a 150-minute resting period, an exercise session, and a 2-hour oral glucose tolerance test. Researchers measure insulin sensitivity, fat and carbohydrate oxidation, and use stable isotopes to track metabolism. Participants undergo blood sampling to assess hormones, metabolites, and cytokines. The study measures lipolysis rate and glucose tolerance changes when blood lactate is elevated, along with secondary outcomes like insulin sensitivity and various metabolic markers. The trial lasts for an average of two years, during which detailed metabolic data are collected to understand how lactate influences metabolic processes in different states.
CONDITIONS
Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism.
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Each trial includes a basal period followed by exercise and a 2-hour oral glucose tolerance test
Metabolically healthy participants receive either an intravenous lactate infusion to raise blood lactate levels or a saline infusion as a control, while metabolically impaired participants receive only the saline infusion. Participants undergo a trial consisting of a 150-minute basal period, an exercise period, and a 2-hour oral glucose tolerance test (OGTT) during which metabolism and insulin sensitivity are measured.
2 visits (one for each trial in metabolically healthy participants) or 1 visit for metabolically impaired participants
Total: 1 location
1
Facultad de Ciencias del Deporte
San Javier, Murcia, Spain, 30720
Actively Recruiting
R
Ricardo MORA RODRIGUEZ, PhD
J
Jesus Garcia-Pallares, PhD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Chi-An W Emhoff, Laurent A Messonnier, Michael A Horning...
https://pubmed.ncbi.nlm.nih.gov/23788576Kashan Ahmed, Sorin Tunaru, Cong Tang...
https://pubmed.ncbi.nlm.nih.gov/20374963Mette G B Pedersen, Nikolaj Rittig, Maj Bangshaab...
https://pubmed.ncbi.nlm.nih.gov/38324259E Ferrannini, A Natali, L S Brandi...
https://pubmed.ncbi.nlm.nih.gov/8214058Terry E Jones, Walter J Pories, Joseph A Houmard...
https://pubmed.ncbi.nlm.nih.gov/31253418